Amwill Health Care Limited is an India-based derma-cosmetic development company. The core focus of the Company is the development of problem-solving dermatological, cosmeceutical, and aesthetical products. The product portfolio of the Company is divided into two categories, namely, development and contract manufacturing of generic dermatological solutions; and developing and formulating solutions to specific dermatological problems. It has a portfolio of products across various problem areas including hair care, skin care and lip care. Its product categories include anti acne, dry skin, anti-fungal, anti-histaminic, anti-perspirant, anti-biotics, skin lightening, special haircare, vitiligo, sunscreen, antioxidants, anti-scabies, and others. The products developed by the Company include Decomedo Gel, Pustulex Gel, Avertage Pro Cream, Histocross 180 Tabs, Depimed Ultra Cream 30 Gm, Ultra Kromaglo Effervescent Tablets, Depimed Tx Tablets, and Ultra Kromaglo Cream, among others.As of 25 May 2026, Amwill Health Care Limited share price is ₹32.38. The stock opened at ₹30.85, compared to its previous close of ₹30.85. During today's trading session, Amwill Health Care Limited share price moved in the range of ₹30.85 to ₹32.38, with an average price of ₹31.62 for the day. Looking at its last 52-week, the stock has touched a low of ₹30.85 and a high of ₹32.38.
The market capitalization of Amwill Health Care Limited is ₹62 Crs, with a P/E ratio of 12.9 and a dividend yield of 0.00%.